Stock Screener App

Frei -

Installieren

4.26

0.70% -0.03

after-market

Handel nachbörslich: 4.26

Ironwood Pharmaceuticals Inc (IRWD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

IRWD stock gains as Wells Fargo conference spotlight shifts to cash flow - AD HOC NEWS

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance

Ironwood Pharmaceuticals (IRWD) Slips 2.6% as Shares Approach Key Support at $3.92Backspread Trade - vinanet.vn

Ironwood Pharmaceuticals Inc. Class A (IRWD) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Ironwood Pharmaceuticals: High Dependence On Its Next Trial (NASDAQ:IRWD) - Seeking Alpha

Ironwood (IRWD) Results Versus Estimates: EPS Does Not Reach the Reported Estimate for the Current Session; Market Move: The Market Price Moves 1.16% Higher in Latest TradingEarnings Yield Analysis - vinanet.vn

Ironwood Pharmaceuticals (IRWD) Edges Higher: Shares Advance 1.16% as Bulls Defend Key SupportRSI Oversold Picks - vinanet.vn

Jeffrey Silber Net Worth (2026) - GuruFocus

Bank of America Corp DE Sells 2,838,753 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Ironwood Pharmaceuticals | ARS: Annual Report to Security Holders - Moomoo

Ironwood Pharmaceuticals (IRWD) Q2 2026 Earnings: EPS Misses Estimates, Stock Climbs 5.64%Dividend Growth Analysis - vinanet.vn

Armistice Capital (IRWD) discloses 13.9M-share Ironwood Pharmaceuticals stake - Stock Titan

Dimensional Fund Advisors LP Raises Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Ironwood Pharmaceuticals, Inc. $IRWD Shares Sold by Amundi - MarketBeat

Ironwood Pharmaceuticals (NASDAQ:IRWD) Downgraded to Buy Rating by Wall Street Zen - MarketBeat

State Street Corporation (NYSE: IRWD caretaker) holds 5.4% of Ironwood common stock - Stock Titan

Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Pacer Advisors Inc. Makes New $3.98 Million Investment in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call High - GuruFocus

Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed? - Yahoo! Finance Canada

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ... - Yahoo Finance

IRWD Looks 15.8% Undervalued on GF Value™ as Debt Reduction Effo - GuruFocus

Ironwood Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Ironwood Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:IRWD) 2026-08-06 - Seeking Alpha

Is Ironwood Pharmaceuticals (IRWD) Undervalued After Q2 Earnings - GuruFocus

IRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingView

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates - Yahoo Finance

Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Ironwood Raises 2026 Guidance After Q2 Revenue Hits $113 Million - Quiver Quantitative

BRIEF-Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million - TradingView

Press Release: Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - Moomoo

Segall Bryant & Hamill LLC Buys New Position in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Lazard Asset Management LLC Sells 710,256 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Ironwood Pharmaceuticals (IRWD) Advances 2.89% to $4.27 — Key Resistance at $4.48 in FocusRevenue Growth Stocks - vinanet.vn

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Large Volume IncreaseWhat's Next? - MarketBeat

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to "Hold" at Zacks Research - MarketBeat

Ironwood Pharmaceuticals (IRWD) Surges 13% as Biotech Momentum BuildsLow Vol Factor - vinanet.vn

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 8.7%Should You Buy? - MarketBeat

Ironwood Pharmaceuticals Q1 2026 Earnings: Slight EPS Miss Overshadowed by Positive Stock MomentumEPS Revision Trend - vinanet.vn

Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

BlackRock, Inc. (NASDAQ: IRWD) discloses 8.1% beneficial stake in Ironwood - Stock Titan

Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey

Return on assets % of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView

Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView

Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

AbbVie Seeks Block On Alkem Generic Constipation Drug - Law360

Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – BX:I76 - TradingView

Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – SWB:I76 - TradingView

Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

IRWD|Ironwood Pharmaceuticals Inc|Price:4.265|Chg%:-0.025 - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

IRWD|Ironwood Pharmaceuticals Inc|Price:3.710|Chg%:-0.080 - TradingKey

Ironwood Pharmaceuticals Inc (I76.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

IRWD: Ironwood Pharmaceuticals IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Globeflex Capital L P Purchases New Shares in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Ironwood Pharmaceuticals (IRWD) grants 137,036-share RSU new-hire award to CMO - Stock Titan

Ironwood Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- Silber Jeffrey - Moomoo

Ironwood Pharmaceuticals (IRWD) Jefferies 2024 Global Healthcare Conference Summary - Quartr

Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating - Moomoo

Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development, STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients - marketscreener.com

Here's why Ironwood Pharmaceuticals (IRWD) is a strong momentum stock - MSN

Ironwood’s 30-year medical chief retires as Phase 3 trial recruits - Stock Titan

Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD) - Seeking Alpha

Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise - Stock Titan

Insider Sell Alert: Ronald Silver Sells Shares of Ironwood Pharm - GuruFocus

Form 4 Ironwood Pharmaceuticals Inc For: 9 July - Investing.com India

ALKS

$46.10

1.66%

RDY

$11.97

0.50%

ELAN

$24.50

0.33%

NBIX

$155.64

1.71%

VTRS

$16.88

0.35%

UTHR

$487.61

0.54%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters